The ataxia telangiectasia mutated kinase pathway regulates IL-23 expression by human dendritic cells.

Targeting XRCC1 deficiency in breast cancer for personalized therapy.

Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.

Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors.

Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla.

MAGIC in practice: experience of peri-operative ECF/X chemotherapy in gastro-esophageal adenocarcinomas.

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study.

Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy.

Base excision repair factors are promising prognostic and predictive markers in cancer.

Purification and specific assays for measuring APE-1 endonuclease activity.

Evolving drug targets in DNA base excision repair for cancer therapy.

RNase III initiates rapid degradation of proU mRNA upon hypo-osmotic stress in Escherichia coli.

Consensus physical activity guidelines for Asian Indians.

Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines.